A class-action lawsuit has been filed against the hospital and its parent company, Mass General Brigham.
Salem Hospital potentially exposed hundreds of patients to HIV or hepatitis due to negligent administration of intravenous medications.
The hospital has stated that the risk of infection is very low and no infections have been identified.
Salem Hospital in Massachusetts is currently facing a class-action lawsuit after potentially exposing hundreds of patients to HIV or hepatitis due to negligent administration of intravenous medications during endoscopy procedures between June 2021 and April 2023. The hospital has stated that the risk of infection is very low and no infections have been identified so far.
The issue was identified and corrected earlier this year. The hospital's quality and infection control teams were notified about the situation. All potentially exposed patients have been notified and 90% have either completed, scheduled or declined free testing.
A class-action lawsuit has been filed against the hospital and its parent company, Mass General Brigham, on behalf of a woman who allegedly suffered emotional distress and a decreased quality of life due to the potential exposure. The hospital has not yet responded to the lawsuit.
Nearly 450 patients at Salem Hospital may have been exposed to hepatitis and HIV due to this improper administration of IV medication. The potential exposure affected patients undergoing endoscopy procedures. The hospital has conducted tests for hepatitis B, hepatitis C, and HIV on all potentially affected patients. No evidence of infections resulting from this potential exposure has been found to date.
A class-action lawsuit has been filed against the hospital and its parent company, Mass General Brigham, on behalf of a woman who allegedly suffered emotional distress and a decreased quality of life due to the potential exposure.